$AVXL mention timeline

Anavex Life Sciences. Every tracked FinTwit mention of $AVXL, newest first. 16 mentions since the first on Sep 9, 2025. See the price chart.

May 2026 · 2 mentions

May 6
Adam Feuerstein ✡️ — $AVXL CEO Chris Missling - fired. The 8K spells it out. Terminated for cause. https://t.co/HzBCPfX0gV One of biotech's worst peddlers of bullshit is gone. I might actually mis…↗
May 6
Adam Feuerstein ✡️ — $AVXL - CEO Chris Missling is out. The board asked for his resignation. https://t.co/sU1FgH5mdE↗

Mar 25
Adam Feuerstein ✡️ — $AVXL pulled its blarcamesine Alzheimer's application from the EMA after regulators there said there was no fking way it was going to approve a drug that does not work. <sad t…↗

Dec 12
Adam Feuerstein ✡️ — $AVXL blarcarmesine formally rejected by EMA's CHMP advisers. The review is brutal: https://t.co/jMP61Cmplk https://t.co/S8UgDKktCE↗

Nov 14
Adam Feuerstein ✡️ — When $AVXL finally ends, CEO Chris Missling should put together an exhibition of the AI-generated "art" he inserts into the company's press releases. We could all attend the show a…↗
Nov 14
Adam Feuerstein ✡️ — $AVXL news, after all! CHMP negative trend vote. Goodbye! https://t.co/RmhXVsTYQK↗
Nov 14
Adam Feuerstein ✡️ — $AVXL - No CHMP recommendation this month, wait for December. https://t.co/FNJDcnd8jt↗
Nov 13
Adam Feuerstein ✡️ — @Sanctuary_Bio My first $AVXL (skeptical/negative, of course) was Nov. 2015. The effort to promote Anavex Life Sciences with claims of a cure for Alzheimer’s disease began this…

Oct 29
Adam Feuerstein ✡️ — $AVXL in full panic mode. With EMA rejection of blarcamesine looming, the company must be trying to sell as much stock as it can with the $150M ATM in place. That explains this mor…↗
Oct 23
Adam Feuerstein ✡️ — Time is running out for Anavex $AVXL and its treatment for Alzheimer’s disease. EMA rejection is coming. https://t.co/Q0BxxmB7s0↗
Oct 13
Adam Feuerstein ✡️ — @jackbsadler $AVXL Likely too early, yes. “No withdrawal” is not positive news, also just too early. Either a rejection or withdrawal is coming 99.9999%, just a matter of when.↗
Oct 13
Adam Feuerstein ✡️

Sep 10
Adam Feuerstein ✡️ — @Biotenic $AVXL is in a bind bc EMA CHMP opinions are published. Timing is likely end of year, beginning of '26, depending on when the drug hits the CHMP agenda. Missling could wit…↗
Sep 9
Adam Feuerstein ✡️ — Every time you see another $AVXL press release touting some arcane analysis of blarcamesine in Alzheimer's disease, please remember: The drug failed, it does nothing, and CEO Chris…↗